Search
for
Sort by
Research 511–540 of 1000+
- Polycystic ovary syndrome (PCOS)
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Comparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil
- Androgen replacement therapy in women
- Adrenal causes of endocrine hypertension in childhood or adolescence
- Androgen excess: a hallmark of polycystic ovary syndrome
- Actualités du SOPK
- An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Is dehydroepiandrosterone a hormone?
- Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Vitamin D metabolism and function in the skin
- Testosterone therapy for transgender men
- Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues